Cancer
GSK cancer vaccine fails again
March 20, 2014Sales and Marketing Cancer, GSK, MAGE-A3 cancer immunotherapeutic, NSCLC, lung cancer, melanoma
GlaxoSmithKline’s MAGE-A3 cancer immunotherapeutic has delivered another late-stage blow to the firm but it still vows to continue trials. The …
Boehringer’s first cancer drug gains NICE yes
March 17, 2014Sales and Marketing Boehringer, Cancer, NICE, NSCLC, afatinib, giotrif
NICE is recommending that Boehringer Ingelheim’s first oncology treatment Giotrif be funded by the NHS. The new final draft guidance …
Amgen melanoma vaccine shrinks tumours
March 17, 2014Research and Development, Sales and Marketing Amgen, Cancer, Yervoy, melanoma, t-vec
Amgen’s investigational cancer vaccine T-vec has managed to shrink the size of advanced melanoma tumours in a late-stage trial. The …
Roche test for HPV recommended by FDA committee
March 13, 2014Sales and Marketing Cancer, FDA, HPV, Roche, cervical, cobas
An FDA advisory committee has recommended that a DNA test developed by Roche be approved for use as a primary …
Breaking into the oncology market
March 10, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boehringer, Cancer, NSCLC, edwards, gilotrif, oncology
In many ways, the US approval of Boehringer’s Gilotrif for patients with late-stage non-small cell lung cancer (NSCLC) last year …
Roche lung cancer drug fails
March 3, 2014Research and Development, Sales and Marketing Cancer, MetMAb, NSCLC, Roche, Tarceva, avastin
An independent data monitoring committee has told Roche to halt a study of its experimental lung cancer drug MetMab due …
NICE rejects Alimta
February 28, 2014Sales and Marketing Alimta, Cancer, NHS, NICE, NSCLC, lilly, pemetrexed
Eli Lilly is coming to terms with rejection by NICE after the cost watchdog said it would not recommend Alimta …
NICE restricts Yervoy use
February 25, 2014Sales and Marketing BMS, Cancer, NHS, NICE, Yervoy, melanoma
Bristol-Myers Squibb has been dealt a blow by NICE after the UK cost watchdog recommended that the use of skin …
A treatment room view
February 24, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CDF, Cancer, NHS, NICE, Roche, avastin, hinsely
A little more than a year ago, Lisa Hinsley’s prospects were not good. The mother of three had been diagnosed …
Drug sellers charged for smuggling cancer drugs into US
February 18, 2014Manufacturing and Production, Sales and Marketing Cancer, FDA, US, smuggling
Two individuals in the US have been prosecuted for smuggling adulterated and misbranded prescription cancer treatments from Turkey and other …
Genes in Space – you don’t need a lab coat to cure cancer
February 18, 2014Medical Communications, Sales and Marketing CRUK, Cancer, app, digital, games, genes in space
As the UK’s leading cancer research charity launches a new gaming app for smartphones, Pharmafile talks to CRUK about just …
Novartis pays out for US biotech
February 17, 2014Research and Development, Sales and Marketing Cancer, Novartis, Vaccine, costim pharmaceuticals
Novartis is looking to shore up its cancer immunotherapy pipeline with the purchase of oncology specialist CoStim Pharmaceuticals. The Cambridge, …
Kadcyla launches in UK
February 13, 2014Sales and Marketing CDF, Cancer, Kadcyla, NHS, Roche, breast
Roche’s Kadcyla, indicated to treat an aggressive form of breast cancer, has launched today in the UK.Kadcyla (trastuzumab emtansine) which …
AbbVie expands into Singapore
February 10, 2014Manufacturing and Production, Sales and Marketing AbbVie, Abbott, Asia, Cancer, Singapore, oncology
AbbVie is expanding its manufacturing operation into Asia for the first time with a $320 million investment in a new …
Cancer awareness campaign slated
February 7, 2014Medical Communications, Sales and Marketing Cancer, adverts, pancreatic, research uk, testicular
An ad campaign by Pancreatic Cancer Action has drawn criticism from other charities for ‘pitting’ different types of cancer against …
Latest content
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion
